Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Foralumab TZLS-401 50 µg
DRUG
2 trials
Sponsors
Brigham and Women's Hospital
, Tiziana Life Sciences LTD
Conditions
Alzheimers Disease
Dementia
Mild Cognitive Impairment Due to Alzheimer's Disease
Non-Active Secondary Progressive Multiple Sclerosis
Phase 2
Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
Recruiting
NCT06489548
Brigham and Women's Hospital
Alzheimers Disease, Dementia, Mild Cognitive Impairment Due to Alzheimer's Disease
Start: 2025-09-16
End: 2026-12-01
Target: 16
Updated: 2026-02-12
Unknown Phase
Intermediate-Size Patient Population Expanded Access: Foralumab in Non-Active Secondary Progressive MS Patients
NCT06802328
Tiziana Life Sciences LTD
Non-Active Secondary Progressive Multiple Sclerosis
Updated: 2025-06-06